Fuentes CMA, Sarduy PMA, Cintra CD, Presno LMC, Barnes DJA, Pérez PJA

Language: Spanish
References: 28
Page:
PDF size: 73.60 Kb.

ABSTRACT

Background: community-Acquired Pneumonias are an important health problem in the world and our country is not exempted from them. There is a high morbidity and mortality from this cause, being pneumonias the fourth cause of death in Cuba.
Objective: to deepen in the knowledge of Community-Acquired Pneumonias to contribute to improve the quality of the attention of these patients in Primary Health Care.
Development: we made emphasis on the aspects related to the concept, pathogenesis, diagnosis, evolution and prognosis including the correct evaluation of the patient, the management of the disease and the current recommended treatment in accordance with our possibilities and the habitual praxis in our environment. Finally, we also made emphasis on the criteria for referral to other health care level, after the correct follow-up of the infectious process in the community.
Conclusions: community-Acquired Pneumonias constitute a common and frequent health problem which should be properly faced from the Primary Health Care by the medical staff. The aid of practical guidelines and prognostic scales contributes to improving the quality in the attention of these patients, from the family doctor's offices to the patient who is admitted to home or hospital.

REFERENCES

1. Rocca GR. Temas de Medicina Interna. 4ta ed. Tomo I, III. La Habana: Editorial Ciencias Médicas, 2002; 150-160, 211, 485.

2. Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M. El Manual Merck. 11ma ed. España: ELSEVIER, 2007; 456-463.

3. González OE. Atención Integral a la tuberculosis y enfermedades respiratorias (AITER/PAL). Guías de prácticas clínicas. La Habana: Molinos Trade, 2009; 29-35.

4. Cotran RS, Kumar V, Robins SL. Patología Estructural y funcional. T III. 5ta edición. Madrid: Mc Graw-Hill, 2005; pág 767-771.

5. Pennington, J.E. Respiratory infections: Diagnosis and management. New York, Raven Pren Press, 1988.

6. Rogelio PP. Andrés PL, Jorge SH, Juan C. VG. Influenza por el nuevo virus A H1N1. Un panorama integral. México: graphimedic, 2010; pág 258.

7. Fauci SA, Braunwual E, Casper DL. Principles of Internal Medicine. Harrison´s. 17th Ed. México: Mac Graw-Hill, 2008; 5, 128.

8. Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J, 2000; 15 (4): 757-63.

9. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA, 1996; 275 (2): 134-41.

10. Anuario Estadístico. La Habana: MINSAP - DNE, 2011.

11. Martín J.J, Dorado A, Jiménez P.E, Escobedo M.C. Neumonía Adquirida en la comunidad en Neumología y Cirugía Torácica. España: SEPAR, 2010; 499-509.

12. Cabrera PN, Rodríguez FC. Manual de enfermedades respiratorias. 2 da ed. España: Universidad de Gran Canarias, 2005; 275.

13. Rico FG. La neumología en la encrucijada de la modernidad. Ed. Centro Médico Nacional La Raza. México, 2010; 169-174.

14. Harrison´s. Principios de Medicina Interna. 17 th Edición. México: Mc Graw-Hill, 2008; cap 251,1230-5.

15. Carratalá JL. Health care associated pneumonia requering hospital admission; Epidemiology, antibiotic therapy and clinical outcomes. Arch Intern Med, 2007; 167 (13): 1393-99.

16. Hannah JD, Charlote S. Cambios en el manejo de la NAC. Una revisión de los dos últimos años. BMJ, 2008; 336: 1429-33.

17. Farr BM, Bartlett CL, Wadsworth J, Miller DL. Risk factors for community-acquired pneumonia diagnosed upon hospital admission, British Thoracic Society Pneumonia Study Group. Resp Med, 2000; 94: 954-63.

18. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Cambell G, et al. American Society Guidelines for the management of adults with community_acquired pneumonia. AM j Respir Crit Care Med, 2001; 163: 1730-54.

19. Alfageme I. Grupo de estudio de la neumonía adquirida en la comunidad: Area de tuberculosis e infecciones respiratorias (Tir-SEPAR). Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Arch Bronconeumol, 2005; 41(5):272-89.

20. Mandell A, Wunderink RG, Anzueto A, Bartlett JG, Cambell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guideline on the Management of Community Acquired Pneumonia in adults. Clin Infect Dis, 2007; 44: (Suppl 2): S27-72.

21. Nuorti P, Butler J, Farley M, Harrison L, McGeer A, Kolczak M, et al. The active bacterial core surveillance team. Ciagarette smoking and invasive pneumococal disease.N England J Med, 2000; 342:681-9.

22. Sociedad Española de Neumología y Cirugía torácica (SEPAR). Normativa de Neumonía Adquirida en la Comunidad. España. Editorial Respira. 2010.

23. Sociedad Española de Neumología y Cirugía torácica (SEPAR), Sociedad Española de Quimioterapia (SEQ), Sociedad Española de Medicina Interna (SEMI) y Sociedad Española de Medicina de Urgencias y Emergencias (SEMES). Tratamiento antibiótico empírico inicial de la Neumonía Adquirida en la comunidad en el paciente adulto inmunocompetente. Rv Esp Quimioter, 2003; 16: 457-66.

24. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weisfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community _ adquired pneumonia. N Engl J Med, 1997; 336: 246-50.

25. Larkin M. Physicians urgend to help patients quit smoking. Lancet, 2002; 359: 1041.

26. Baver TT, Ewin S, Marre R, Suttorp N, Welte T. Capnetz Study Group, CRB 65 predicts death from community-adquired pneumonia. J Intern Med, 2006; 260: 93- 101.

27. Sanz HF, Marina MN, Montull VB, San Juan LM. Arch. de bronconeumol. 2010; 46(Supl 6):22-26.

28. Garrison SJ. Manual de Medicina Física y Rehabilitación. 2da Edición. La Habana: ECIMED; 2006.